Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery

Neuro-Oncology

Volumn 6, Issue 2, 2004, Pages 104-112

  Vavra, Michael ^a   Ali, M Jaffer ^b   Kang, E W Y ^a   Navalitloha, Yot ^a   Ebert, Allison ^a   Allen, Cathleen V ^b   Groothuis, Dennis R ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; SUCROSE; CARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN TUMOR; CANCER TISSUE; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG INFUSION; GLIOMA; HISTOPATHOLOGY; NONHUMAN; RADIOACTIVITY; RAT; SUBCUTANEOUS TISSUE TUMOR; THERMODYNAMICS; TISSUE DISTRIBUTION; TISSUE NECROSIS; TISSUE SECTION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; FISCHER 344 RAT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; DRUG DELIVERY SYSTEMS; GLIOMA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; RATS; RATS, INBRED F344; SUCROSE; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 1842588861     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000449     Document Type: Article

References (31)

1. Baxter, L.T., and Jain, R.K. (1989) Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res. 37, 77-104.
2. Blasberg, R.G., Groothuis, D.R., and Molnar, P. (1981) Application of quantitative autoradiographic measurements in experimental brain tumors. Semin. Neurol. 1, 203-224.
3. Bobo, R.H., Laske, D.W., Akbasak, A., Morrison, P.F., Dedrick, R.L., and Oldfield, E.H. (1994) Convection enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA 91, 2076-2080.
4. Boucher, Y., and Jain, R.K. (1992) Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: Implications for vascular collapse. Cancer Res. 52, 5110-5114.
5. Boucher, Y., Baxter, L.T., and Jain, R.K. (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy. Cancer Res. 50, 4478-4484.
6. Boucher, Y., Salehi, H., Witwer, B., Harsh, G.R. 4th, and Jain, R.K. (1997) Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br. J. Cancer 75, 829-836.
7. Bruce, J.N., Falavigna, A., Johnson, J.P., Hall, J.S., Birch, B.D., Yoon, J.T., Wu, E.X., Fine, R.L., and Parsa, A.T. (2000) Intracerebral clysis in a rat glioma model. Neurosurgery 46, 683-691.
8. Cserr, H.F., Cooper, D.N., Suri, P.K., and Patlak, C.S. (1981) Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am. J. Physiol. 240, F319-F328.
9. Giussani, C., Carrabba, G., Pluderi, M., Lucini, V., Pannacci, M., Caronzolo, D., Costa, F., Minotti, M., Tomei, G., Villani, R., Bikfalvi, A., and Bello, L. (2003) Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res. 63, 2499-2505.
10. Groothuis, D.R., Fischer, J.M., Pasternak, J.F., Blasberg, R.G., Bigner, D.D., and Vick, N.A. (1983a) Regional measurements of blood-to-tissue transport in transplanted RG-2 rat gliomas. Cancer Res. 43, 3368-3373.
11. Groothuis, D.R., Pasternak, J.F., Fischer, J.M., Blasberg, R.G., Vick, N.A., and Bigner, D.D. (1983b) Regional measurements of blood flow in transplanted RG-2 rat gliomas. Cancer Res. 43, 3362-3367.
12. 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion. J. Neurosurg. 90, 321-331.
13. Hassenbusch, S., Levin, V., Cozzens, J., Paleologos, N., Smith, D., Phuphanich, S., Brem, S., Chen, T., Chamberlain, M., Hariharan, S., Krouwer, H., Mueller, W., Resnick, G., and Pietronigro, D. (2002) Multi-center phase I/II trial of stereotactic injection of DTI-015 into inoperable recurrent malignant glioblastoma multiforme. Neuro-oncol. 4, S43 (abstract).
14. Heimberger, A.B., Archer, G.E., McLendon, R.E., Hulette, C., Friedman, A.H., Friedman, H.S., Bigner, D.D., and Sampson, J.H. (2000) Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats. Clin. Cancer Res. 6, 4148-4153.
15. Jain, R.K. (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9, 253-266.
16. Kaiser, M.G., Parsa, A.T., Fine, R.L., Hall, J.S., Chakrabarti, I., and Bruce, J.N. (2000) Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neurosurgery 47, 1391-1398.
17. Kristjansen, P.E., Boucher, Y., and Jain, R.K. (1993) Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res. 53, 4764-4766.
18. Laske, D.W., Ilercil, O., Akbasak, A., Youle, R.J., and Oldfield, E.H. (1994) Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg. 80, 520-526.
19. Laske, D.W., and Rossi, P. (2002) Phase II multicenter trial of intratumoral/interstitial therapy with TransMID in patients with refractory and progressive glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) Neuro-oncol. 4, S58 (abstract).
20. Less, J.R., Posner, M.C., Boucher, Y., Borochovitz, D., Wolmark, N., and Jain, R.K. (1992) Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 52, 6371-6374.
21. Mardor, Y., Roth, Y., Lidar, Z., Jonas, T., Pfeffer, R., Maier, S.E., Faibel, M., Nass, D., Hadani, M., Orenstein, A., Cohen, J.S., and Ram, Z. (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res. 61, 4971-4973.
22. Miller, C.R., Williams, C.R., Buchsbaum, D.J., and Gillespie, G.Y. (2002) Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Cancer Res. 62, 773-780.
23. Molnar, P., Fekete, I., Schlageter, K.E., Lapin, G.D., and Groothuis, D.R. (1999) Absence of host-site influence on angiogenesis, blood flow, and permeability in transplanted RG-2 gliomas. Drug Metab. Dispos. 27, 1085-1091.
24. Netti, P.A., Baxter, L.T., Boucher, Y., Skalak, R., and Jain, R.K. (1995) Time dependent behavior of interstitial fluid pressure in solid tumors: Implications for drug delivery. Cancer Res. 55, 5451-5458.
25. Patchell, R.A., Regine, W.F., Ashton, P., Tibbs, P.A., Wilson, D., Shappley, D., and Young, B. (2002) A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme. J. Neurooncol. 60, 37-42.
26. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Orlando: Academic Press.
27. Reardon, D., Akabani, G., Friedman, A., Friedman, H., Herndon, J., McLendon, R., Quinn, J., Rich, J., Penne, K., Sampson, J., Shafman, T, Wong, T., Zalutsky, M., and Bigner, D. (2002) Treatment of patients with newly diagnosed malignant gliomas using iodine 131-labeled human-mouse chimeric antitenascin monoclonal antibody 81C6 via surgically created resection cavities: Phase I/II trial results. Neuro-oncol. 4, S80 (abstract).
28. Schlageter, K.E., Molnar, P., Lapin, G.D., and Groothuis, D.R. (1999) Microvessel organization and structure in experimental brain tumors: Microvessel populations with distinctive structural and functional properties. Microvasc. Res. 58, 312-328.
29. Viola, J.J., Agbaria, R., Walbridge, S., Oshiro, E.M., Johns, D.G., Kelley, J.A., Oldfield, E.H., and Ram, Z. (1995) In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. Cancer Res. 55, 1306-1309.
30. Weber, F.W., and Hingorani, V. (2002) Local treatment of recurrent glioblastoma by bulk infusion of recombinant IL-4 immunotoxin. Neuro-oncol. 4, S101 (abstract).
31. Yang, W., Barth, R.F., Adams, D.M., Ciesielski, M.J., Fenstermaker, R.A., Shukla, S., Tjarks, W., and Caligiuri, M.A. (2002) Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res. 62, 6552-6558.